0001104659-14-022987.txt : 20140326
0001104659-14-022987.hdr.sgml : 20140326
20140326172900
ACCESSION NUMBER: 0001104659-14-022987
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140324
FILED AS OF DATE: 20140326
DATE AS OF CHANGE: 20140326
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ophthotech Corp.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
BUSINESS PHONE: 212-845-8200
MAIL ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PEACOCK BRUCE
CENTRAL INDEX KEY: 0001228459
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 14719524
4
1
a4.xml
4
X0306
4
2014-03-24
0
0001410939
Ophthotech Corp.
OPHT
0001228459
PEACOCK BRUCE
C/O OPHTHOTECH CORPORATION
ONE PENN PLAZA, 19TH FLOOR
NEW YORK
NY
10119
0
1
0
0
CFO & CBO
Common Stock
2014-03-24
4
M
0
6191
1.6520
A
6191
D
Common Stock
2014-03-24
4
S
0
5031
34.71
D
1106
D
Common Stock
2014-03-24
4
S
0
1106
35.03
D
0
D
Stock Option (Right To Buy)
1.6520
2014-03-24
4
M
0
6191
0.00
D
2020-09-27
Common Stock
6191
66750
D
The sale reported on this form was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2013.
These shares were disposed of in multiple transactions on March 24, 2014 at actual sales prices ranging from $33.82 to $34.81 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
These shares were disposed of in multiple transactions on March 24, 2014 at actual sales prices ranging from $34.83 to $35.52 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
This option was granted on September 28, 2010 and is currently exercisable for all shares underlying the option.
/s/ Tom Biancardi, as Attorney-in-Fact for Bruce Peacock
2014-03-26